Why is Pfizer Inc. ?
1
High Management Efficiency with a high ROCE of 16.86%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 2.16 times
3
The company has declared Positive results for the last 3 consecutive quarters
- NET PROFIT(9M) At USD 11,738.38 MM has Grown at 53.8%
- DIVIDEND PER SHARE(HY) Highest at USD 5.44
- RAW MATERIAL COST(Y) Fallen by -3.65% (YoY)
4
With ROCE of 12.73%, it has a very attractive valuation with a 1.99 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 2.26%, its profits have risen by 120.4% ; the PEG ratio of the company is 0.1
- At the current price, the company has a high dividend yield of 428.1
5
Underperformed the market in the last 1 year
- The stock has generated a return of 2.26% in the last 1 year, much lower than market (S&P 500) returns of 14.11%
How much should you hold?
- Overall Portfolio exposure to Pfizer Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Pfizer Inc. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Pfizer Inc.
1.95%
-0.30
26.68%
S&P 500
20.78%
0.70
20.15%
Quality key factors
Factor
Value
Sales Growth (5y)
5.60%
EBIT Growth (5y)
7.73%
EBIT to Interest (avg)
12.68
Debt to EBITDA (avg)
2.16
Net Debt to Equity (avg)
0.50
Sales to Capital Employed (avg)
6,258.25
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
126.47%
Pledged Shares
0
Institutional Holding
68.35%
ROCE (avg)
16.86%
ROE (avg)
21.23%
Valuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
2.67
EV to EBIT
15.12
EV to EBITDA
11.12
EV to Capital Employed
2.08
EV to Sales
4.47
PEG Ratio
0.07
Dividend Yield
407.26%
ROCE (Latest)
13.77%
ROE (Latest)
18.34%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
Technical Movement
0What is working for the Company
NO KEY POSITIVE TRIGGERS
-11What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD 6,356 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 0 times
INTEREST COVERAGE RATIO(Q)
Lowest at 518.71
CASH AND EQV(HY)
Lowest at USD 14,984 MM
DEBTORS TURNOVER RATIO(HY)
Lowest at 0 times
OPERATING PROFIT(Q)
Lowest at USD 3,688 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 21.01 %
EPS(Q)
Lowest at USD -0.29
Here's what is not working for Pfizer Inc.
Interest Coverage Ratio
Lowest at 518.71
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Inventory Turnover Ratio
Lowest at 0 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Operating Cash Flow
Lowest at USD 6,356 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Operating Profit
Lowest at USD 3,688 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at 21.01 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
EPS
Lowest at USD -0.29
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Cash and Eqv
Lowest at USD 14,984 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio






